About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

CTCL Directed Therapy

NCT03116659·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Ali Dana, MD
CONTACT
718-584-9000 Ali.Dana@VA.gov

Lead

James J. Peters Veterans Affairs Medical Center

Age

30–89

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients age 30 - 89 years old
Stages I to II CTCL patients
Normal renal function, Cr ≤ 1.5

You may not be if

Aggressively progressing CTCL
Active infection and/or concurrent malignancy
Poor renal function (Cr \> 1.5)
Pregnancy (HCG serum +)
History of bone marrow suppression, MDS, anemia (Hemoglobin \< 8), thrombocytopenia (\< 50,000) or neutropenia (ANC \< 1500)
CHF, MI within last 6 months
Endocarditis
Allergies to Imiquimod or doxycycline

The record

StatusUnknown

PhaseEarly phase 1

Taking part8

StartedFeb 2018

UpdatedAug 13, 2019

Conditions

Lymphoma, T-Cell, Cutaneous

Where1

James J Peters Bronx Veterans Affairs Medical Center
The Bronx, New York, United States

Clareo Health | CTCL Directed Therapy